*ST Huicheng: Signs financial restructuring investment agreement with Zhenen Biotech and others

NightAirdropper · 2026-04-04T02:27:56+00:00

*ST Huicheng has signed an agreement with the restructuring investors. The financial investor will invest 230 million yuan to acquire 114 million shares, which will be used to pay restructuring fees and debt repayment. They have committed not to transfer the shares within 12 months.

NightAirdropper

2026-04-04 02:27:56

Abstract generation in progress

Every Chinese Economic News AI Express, April 1, *ST Huicheng announced that, the company and the restructuring investors Zien Biotech and the financial investors Shanyuanrunhe and Zhongjin Pucheng have signed the “Restructuring Financial Investment Agreement.” According to the agreement, the financial investors plan to collectively obtain 114 million shares of the company’s stock resulting from capital increase, and will pay a total restructuring investment amount of RMB 230 million, corresponding to an equity subscription price of RMB 2.01 per share. Of this, Shanyuanrunhe will contribute approximately RMB 206 million to obtain approximately 102 million shares, while Zhongjin Pucheng will contribute approximately RMB 24 million to obtain 12 million shares. The investment proceeds will be used to pay restructuring expenses, repay debts, and supplement liquidity. If the restructuring plan is approved by the court and implemented, the company will complete the capitalization of capital surplus into share capital, and the financial investors commit to not transfer their shares within 12 months.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.